Nebula Genomics
Nebula Genomics is a U.S.-based whole genome sequencing company offering DTC DNA Complete kits and enterprise sequencing services to pharma, biotech, academic, and population health customers, using a CLIA-certified lab and blockchain-secured data handling.
- Company typePrivate
- Founded2018
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Nebula Genomics does
Nebula Genomics, founded in 2018 by Harvard Medical School Professor of Genetics Dr. George Church and now operated as a service of ProPhase Labs, Inc., provides whole genome sequencing (WGS) to both individual consumers and enterprise customers. Its flagship consumer product, DNA Complete, decodes 100% of a user's DNA from a saliva sample and returns more than 350 personalized health, trait, ancestry, and oral microbiome reports that are continuously updated as new genetic discoveries emerge, marketed in contrast to SNP-chip tests from 23andMe and Ancestry that cover approximately 1% of the genome. Pricing for DTC kits starts at $249 for 30x clinical-grade WGS, with a subscription layer providing ongoing access to the Nebula Library and ancestry reports.
Nebula Genomics firmographics
Firmographics- Name
- Nebula Genomics
- Legal name
- Nebula Genomics, Inc.
- Website
- https://nebula.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nebula Genomics is a U.S.-based whole genome sequencing company offering DTC DNA Complete kits and enterprise sequencing services to pharma, biotech, academic, and population health customers, using a CLIA-certified lab and blockchain-secured data handling.
- Ownership category
- akta.pro rank
Nebula Genomics industry classification
Industry- Product category
- Genetic Testing Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)
Keywords
Where Nebula Genomics is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Nebula Genomics business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- DNA Testing Kits: One-time purchase of DNA collection kits for whole genome sequencing. Consumers purchase the kit, submit saliva sample, and receive genetic reports. Pricing starts at $249 for 30x WGS options with all reports included.
- Subscription/Membership: Ongoing membership providing continuous access to the Nebula Library, ancestry reports, traits, and oral microbiome analysis. Subscription fees are charged for renewal periods with specific terms around cancellation.
- Enterprise Sequencing Services: B2B whole genome sequencing services for pharma, biotech, academic research, and population health organizations. Services include sample collection kits, custom reports (400+ existing or custom panels), white-label solutions, and bioinformatics analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | 30x Whole Genome Sequencing - Starting price for clinical-grade WGS |
| One time/ perpetual license | Pay-as-you-go | 100x Whole Genome Sequencing - Ultra-deep sequencing option |
| Usage-based | Multi-year contract | 1x WGS Enterprise - Cost-effective population screening |
| Usage-based | Multi-year contract | 30x WGS Enterprise - Clinical-grade research sequencing |
| Usage-based | Multi-year contract | 100x WGS Enterprise - Ultra-deep rare disease research |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Nebula Genomics product offering
Product offeringCore offering
Nebula Genomics offers whole genome sequencing (WGS) through its DNA Complete product, decoding 100% of a customer's DNA via an at-home saliva collection kit and delivering 350+ personalized health, ancestry, trait, and oral microbiome reports with continuous updates. The company also provides enterprise B2B genomic sequencing services from a CLIA-certified U.S. laboratory, supplying pharma, biotech, academic, and population-health clients with flexible 1x/30x/100x WGS tiers, custom and white-label reports, and bioinformatics analysis.
Differentiator
Problem solved
Functional benefit
Brands
- DNA Complete by Nebula Genomics: The company's flagship whole genome sequencing product offering that analyzes 100% of DNA, providing health, traits, ancestry, and oral microbiome reports.
Products and services
- DNA Complete by Nebula Genomics Direct-to-consumer at-home whole genome sequencing kit that decodes 100% of a customer's DNA from a saliva sample, delivering 350+ personalized health, ancestry, trait, and oral microbiome reports with continuous updates as new genetic discoveries emerge. Targeted at individual consumers seeking comprehensive personal genomic insights.
- Nebula Genomics Enterprise Sequencing Services B2B whole genome sequencing services from a CLIA-certified U.S. laboratory, offered in 1x, 30x (clinical-grade), and 100x (ultra-deep) tiers for pharma, biotech, academic research, and population-health organizations. Includes chain-of-custody sample collection kits, 400+ curated reports, custom panel development, white-label solutions, and bioinformatics deliverables (CRAM, VCF).
- Nebula Research Library Curated library of 400+ DNA reports based on peer-reviewed scientific publications, covering genetic conditions and traits such as eczema, vitamin D levels, and macular degeneration, available as part of DNA Complete and enterprise sequencing offerings.
- Nebula Genomics Membership / Subscription Recurring membership providing continuous access to the Nebula Library, ancestry reports, trait analyses, oral microbiome results, and continuous report updates as new genetic discoveries emerge, with subscription billing and defined cancellation terms.
Quantifiable outcome
- 350+ personalized health reports across major health categories
- +2 more outcomes
Companies that use Nebula Genomics
Customer profileSegments5 records
Ideal customer profiles4 records
Nebula Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Nebula Genomics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Dante LabsmajorDante Labs and Nebula Genomics announced a merger, combining their whole genome sequencing capabilities and market positions in the consumer genomics space. This consolidation reflects ongoing industry trends toward merger and acquisition activity in the genetic testing sector.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Nebula Genomics competitors and assessment
Company assessmentBroad incumbents
- Invitae: Large clinical genetics company offering a broad menu of genetic tests across hereditary cancer, reproductive health, and rare diseases. Broader incumbent with overlapping enterprise and clinical genomics business though not focused on DTC or whole genome.
- BGI Group: Global genomics conglomerate with WGS services through BGI Genomics and the MGI sequencing instrument platform. Comparable in large-scale sequencing capacity and enterprise B2B genomics services, though far broader in scope and geographic reach.
Direct peers
- Helix: Sequencing-centric platform combining next-generation sequencing with a marketplace of DNA-powered apps. Comparable in offering WGS infrastructure and consumer/enterprise applications, though organized around an app ecosystem model.
- 23andMe: Direct-to-consumer genetic testing leader offering health and ancestry reports. Directly comparable as a consumer-facing DNA testing brand, though 23andMe uses SNP-chip arrays (~1% of DNA) versus Nebula's WGS; serves the same customer need for personal genetic insights.
- Ancestry: Major DTC genetic testing brand focused on ancestry and family history. Directly comparable consumer genomics offering, similarly relying on SNP-chip arrays (~1% of DNA) and competing for the same consumer attention and wallet share.
- Veritas Genetics: Whole genome sequencing provider offering both consumer and clinical/lifestyle products, including myGenome. Direct competitor in the WGS consumer space with similar positioning around comprehensive genomic analysis.
- Human Longevity Inc. Whole genome sequencing-based health intelligence company founded by J. Craig Venter offering comprehensive genomic analysis to consumers and enterprise. Direct WGS-based competitor with similar health-focused value proposition.
- Dante Labs: Whole genome sequencing DTC provider and direct competitor; the two companies announced a merger in 2025. Highly comparable business model, sequencing technology tiering, and customer segments, making this the most direct peer.
- MyHeritage: DTC genetic testing company with strong European presence offering ancestry and health DNA kits. Comparable as a consumer-facing DNA testing brand competing for the same international customer base.
Emerging players
- Color Genomics: Clinical-grade genetic testing company offering hereditary cancer screening, pharmacogenomics, and population genomics programs. Comparable enterprise/clinical genomic services capability, though more focused on panel-based testing than WGS.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Nebula Genomics social profiles
Digital presenceNebula Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nebula Genomics leadership team
Management profileNumber of profiles
Profiles4 records
Nebula Genomics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nebula Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nebula Genomics
What does Nebula Genomics do?
Nebula Genomics offers whole genome sequencing (WGS) through its DNA Complete product, decoding 100% of a customer's DNA via an at-home saliva collection kit and delivering 350+ personalized health, ancestry, trait, and oral microbiome reports with continuous updates. The company also provides enterprise B2B genomic sequencing services from a CLIA-certified U.S. laboratory, supplying pharma, biotech, academic, and population-health clients with flexible 1x/30x/100x WGS tiers, custom and white-label reports, and bioinformatics analysis.
Is Nebula Genomics a public or private company?
Nebula Genomics is a private company. It is classified as corporate owned and is currently operating.
When was Nebula Genomics founded?
Nebula Genomics was founded in 2018. It employs 1 to 10 people.
Where is Nebula Genomics based?
Nebula Genomics is headquartered in San Francisco, United States, in the North America region.
How does Nebula Genomics make money?
Three revenue lines are on record. DNA Testing Kits are the primary driver. The others are subscription/Membership and enterprise Sequencing Services.
Who are Nebula Genomics's main competitors?
Broad incumbents on record are Invitae and BGI Group. Direct peers are Helix, 23andMe, Ancestry, Veritas Genetics, Human Longevity Inc., Dante Labs and MyHeritage. Color Genomics is listed as an emerging player.
Does Nebula Genomics have an API?
No public API is recorded for Nebula Genomics.
What industry is Nebula Genomics in?
Nebula Genomics's product category is Genetic Testing Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.